The epidemiology and natural history of anal human papillomavirus infection in men who have sex with men

Sexual Health

Volumn 9, Issue 6, 2012, Pages 527-537

  MacHalek, Dorothy A ^a   Grulich, Andrew E ^a   Jin, Fengyi ^a   Templeton, David J ^a,b   Poynten, I Mary ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

anal intraepithelial neoplasia; cancer; homosexual.

Indexed keywords

VIRUS DNA;

ANAL HUMAN PAPILLOMAVIRUS INFECTION; ANUS CANCER; ANUS DISEASE; ANUS INTERCOURSE; ARTICLE; CANCER EPIDEMIOLOGY; CD4 LYMPHOCYTE COUNT; CONDYLOMA ACUMINATUM; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; INFECTION RATE; INFECTION RISK; INTESTINAL BLEEDING; MALE; MALE HOMOSEXUAL; MEDLINE; MULTIPLEX POLYMERASE CHAIN REACTION; PAPILLOMAVIRUS INFECTION; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SEX; VIRUS DETECTION; VIRUS TRANSMISSION; WART VIRUS;

ADULT; ANAL CANAL; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CAUSALITY; COMORBIDITY; FEMALE; HOMOSEXUALITY, MALE; HUMANS; INCIDENCE; MALE; MEDICAL HISTORY TAKING; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; RISK-TAKING; UNITED STATES; UNSAFE SEX; WORLD HEALTH;

EID: 84870427038     PISSN: 14485028     EISSN: 14498987     Source Type: Journal    
DOI: 10.1071/SH12043     Document Type: Article

References (77)

1. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, et al. A review of human carcinogens - part B: biological agents. Lancet Oncol 2009; 10(4): 321-2. doi:10.1016/S1470-2045(09) 70096-8
2. Trottier H, Mahmud SM, Lindsay L, Jenkins D, Quint W, Wieting SL, et al. Persistence of an incident human papillomavirus infection and timing of cervical lesions in previously unexposed young women. Cancer Epidemiol Biomarkers Prev 2009; 18(3): 854-62. doi:10.1158/1055-9965.EPI-08-1012
3. zur Hausen H. Papillomaviruses causing cancer: evasion from hostcell control in early events in carcinogenesis. J Natl Cancer Inst 2000; 92(9): 690-8. doi:10.1093/jnci/92.9.690
4. Grulich AE, Jin F, Conway EL, Stein AN, Hocking J. Cancers attributable to human papillomavirus infection. Sex Health 2010; 7(3): 244-52. doi:10.1071/SH10020
5. Jin F, Stein AN, Conway EL, Regan DG, Law M, Brotherton JM, et al. Trends in anal cancer in Australia, 1982-2005. Vaccine 2011; 29(12): 2322-7. doi:10.1016/j.vaccine.2011.01.015
6. Joseph DA, Miller JW, Wu X, Chen VW, Morris CR, Goodman MT, et al. Understanding the burden of human papillomavirus-associated anal cancers in the US. Cancer 2008; 113(S10): 2892-900. doi:10.1002/cncr.23744
7. Frisch M. On the etiology of anal squamous carcinoma. Dan Med Bull 2002; 49(3): 194-209.
8. D'Souza G, Wiley DJ, Li X, Chmiel JS, Margolick JB, Cranston RD, et al. Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr 2008; 48(4): 491-9. doi:10.1097/QAI.0b013e31817aebfe
9. Machalek DA, Poynten M, Jin F, Fairley CK, Farnsworth A, Garland SM, et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol 2012; 13(5): 487-500. doi:10.1016/S1470-2045(12)70080-3
10. Daling JR, Weiss NS, Hislop TG, Maden C, Coates RJ, Sherman KJ, et al. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med 1987; 317(16): 973-7. doi:10.1056/ NEJM198710153171601
11. Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004; 101(2): 270-80. doi:10.1002/cncr.20365
12. Silverberg MJ, Lau B, Justice AC, Engels E, Gill MJ, Goedert JJ, et al. Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis 2012; 54(7): 270-80. doi:10.1093/cid/ cir1012
13. Gervaz P, Hirschel B, Morel P. Molecular biology of squamous cell carcinoma of the anus. Br J Surg 2006; 93(5): 531-8. doi:10.1002/ bjs.5376
14. Watson AJ, Smith BB, Whitehead MR, Sykes PH, Frizelle FA. Malignant progression of anal intra-epithelial neoplasia. ANZ J Surg 2006; 76(8): 715-7. doi:10.1111/j.1445-2197.2006.03837.x
15. Bernard HU, Burk RD, Chen Z, van Doorslaer K, Hausen H, de Villiers EM. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 2010; 401(1): 70-9. doi:10.1016/j.virol.2010.02. 002
16. Schiffman M, Herrero R, Desalle R, Hildesheim A, Wacholder S, Rodriguez AC, et al. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 2005; 337(1): 76-84. doi:10.1016/j.virol.2005.04.002
17. Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, et al. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 2008; 26(Suppl 10): K1-16. doi:10.1016/ j.vaccine.2008.05.064
18. Lacey CJ, Lowndes CM, Shah KV. Chapter 4: burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine 2006; 24: 35-41.
19. Doorbar J, Raj K. Biology of papillomavirus replication in infected epthelium. Future Virol 2007; 2(6): 573-86.
20. Herfs M, Hubert P, Moutschen M, Delvenne P. Mucosal junctions: open doors to HPV and HIV infections? Trends Microbiol 2011; 19(3): 114-20. doi:10.1016/j.tim.2010.12.006
21. Jay N, Berry JM, Hogeboom CJ, Holly EA, Darragh TM, Palefsky JM. Colposcopic appearance of anal squamous intraepithelial lesions: relationship to histopathology. Dis Colon Rectum 1997; 40(8): 919-28. doi:10.1007/BF02051199
22. Mukonoweshuro P, Oriowolo A, Smith M. Audit of the histological definition of cervical transformation zone. J Clin Pathol 2005; 58(6): 671.
23. Northfelt DW, Swift PS, Palefsky JM. Anal neoplasia. Pathogenesis, diagnosis, and management. Hematol Oncol Clin North Am 1996; 10(5): 1177-87. doi:10.1016/S0889-8588(05)70392-0
24. Ostör AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993; 12(2): 186-92. doi:10.1097/00004347- 199304000-00018
25. Stoler MH, Schiffman M. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA 2001; 285(11): 1500-5. doi:10.1001/jama.285.11. 1500
26. Agorastos T, Miliaras D, Lambropoulos AF, Chrisafi S, Kotsis A, Manthos A, et al. Detection and typing of human papillomavirus DNA in uterine cervices with coexistent grade I and grade III intraepithelial neoplasia: biologic progression or independent lesions? Eur J Obstet Gynecol Reprod Biol 2005; 121(1): 99-103. doi:10.1016/j.ejogrb.2004.11.024
27. De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 2009; 124 (7): 1626-36. doi:10.1002/ijc.24116
28. Gohy L, Gorska I, Rouleau D, Ghattas G, Pokomandy A, Vezina S, et al. Genotyping of human papillomavirus DNA in anal biopsies and anal swabs collected from HIV-seropositive men with anal dysplasia. J Acquir Immune Defic Syndr 2008; 49(1): 32-9. doi:10.1097/ QAI.0b013e318183a905
29. Parkin DM, Bray F. Chapter 2: the burden of HPV-related cancers. Vaccine 2006; 24: 11-25.
30. Hoots BE, Palefsky JM, Pimenta JM, Smith JS. Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer 2009; 124(10): 2375-83. doi:10.1002/ijc.24215
31. Darragh TM, Winkler B. Anal cancer and cervical cancer screening: key differences. Cancer cytopathology 2011 25 Feb; 119(1): 5-19. doi:10.1002/cncy.20126
32. Lina Villa L, Denny L. Chapter 7: methods for detection of HPV infection and its clinical utility. Int J Gynaecol Obstet 2006; 94: S71-80. doi:10.1016/S0020-7292(07)60013-7
33. Snijders PJ, Heideman DA, Meijer CJ. Methods for HPV detection in exfoliated cell and tissue specimens. APMIS 2010; 118(6-7): 520-8. doi:10.1111/j.1600-0463.2010.02621.x
34. Molijn A, Kleter B, Quint W, van Doorn LJ. Molecular diagnosis of human papillomavirus (HPV) infections. J Clin Virol 2005; 32(Suppl 1): S43-51. doi:10.1016/j.jcv.2004.12.004
35. Rebolj M, Bonde J, Njor SH, Lynge E. Human papillomavirus testing in primary cervical screening and the cut-off level for hybrid capture 2 tests: systematic review. BMJ 2011; 342: d2757. doi:10.1136/bmj. d2757
36. Pirotta MV, Stein AN, Fairley CK, Morrow A, Conway EL, Chuah J, et al. Patterns of treatment of external genital warts in Australian sexual health clinics. Sex Transm Dis 2009; 36(6): 375-9. doi:10.1097/OLQ.0b013e3181971e4e
37. Kyriakis KP, Hadjivassiliou M, Paparizos VA, Riga P, Katsambas A. Determinants of genital wart case detection rates among STD clinic attendees in Athens, Greece. Int J Dermatol 2005; 44(8): 650-3. doi:10.1111/j.1365-4632.2004. 02064.x
38. Jin F, Prestage GP, Kippax SC, Pell CM, Donovan B, Templeton DJ, et al. Risk factors for genital and anal warts in a prospective cohort of HIV-negative homosexual men: the HIM study. Sex Transm Dis 2007; 34(7): 488-93.
39. Wiley DJ, Grosser S, Qi K, Visscher BR, Beutner K, Strathdee SA, et al. Validity of self-reporting of episodes of external genital warts. Clin Infect Dis 2002; 35(1): 39-45. doi:10.1086/340743
40. Smith JS, Gilbert PA, Melendy A, Rana RK, Pimenta JM. Agespecific prevalence of human papillomavirus infection in males: a global review. J Adolesc Health 2011; 48(6): 540-52. doi:10.1016/ j.jadohealth.2011.03.010
41. Smith JS, Melendy A, Rana RK, Pimenta JM. Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health 2008 Oct; 43: S5-25. S e1-41.
42. Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, Morales J, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000; 92(6): 464-74. doi:10.1093/jnci/92.6.464
43. Herrero R, Castle PE, Schiffman M, Bratti MC, Hildesheim A, Morales J, et al. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis 2005; 191(11): 1796-807. doi:10.1086/ 428850
44. Goldstone S, Palefsky JM, Giuliano AR, Moreira ED, Aranda C, Jessen H, et al. Prevalence of and risk factors for human papillomavirus (HPV) infection among HIV-seronegative men who have sex with men. J Infect Dis 2011; 203(1): 66-74. doi:10.1093/ infdis/jiq016
45. Chin-Hong PV, Vittinghoff E, Cranston RD, Buchbinder S, Cohen D, Colfax G, et al. Age-specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE study. J Infect Dis 2004; 190(12): 2070-6. doi:10.1086/425906
46. Vajdic CM, Van Leeuwen MT, Jin F, Prestage G, Medley G, Hillman RJ, et al. Anal human papillomavirus genotype diversity and co-infection in a community-based sample of homosexual men. Sex Transm Infect 2009; 85(5): 330-5. doi:10.1136/sti.2008.034 744
47. Gao L, Zhou F, Li X, Yang Y, Ruan Y, Jin Q. Anal HPV infection in HIV-positive men who have sex with men from China. PLoS ONE 2010; 5(12): e15256. doi:10.1371/journal.pone.0015256
48. Nyitray AG, Carvalho da Silva RJ, Baggio ML, Lu B, Smith D, Abrahamsen M, et al. Age-specific prevalence of and risk factors for anal human papillomavirus (HPV) among men who have sex with women and men who have sex with men: the HPV in men (HIM) study. J Infect Dis 2011; 203(1): 49-57. doi:10.1093/infdis/ jiq021
49. Grulich AE, de Visser RO, Smith AM, Rissel CE, Richters J. Sex in Australia: homosexual experience and recent homosexual encounters. Aust N Z J Public Health 2003; 27(2): 155-63. doi:10.1111/j.1467- 842X.2003.tb00803.x
50. de Visser RO, Smith AM, Rissel CE, Richters J, Grulich AE. Sex in Australia: heterosexual experience and recent heterosexual encounters among a representative sample of adults. Aust N Z J Public Health 2003; 27(2): 146-54. doi:10.1111/j.1467-842X.2003. tb00802.x
51. Guimarães MD, Grinsztejn B, Melo VH, Rocha GM, Campos LN, Pilotto JH, et al. Anal HPV prevalence and associated factors among HIV-seropositive men under antiretroviral treatment in Brazil. J Acquir Immune Defic Syndr 2011; 57(Suppl 3): S217-24. doi:10.1097/QAI.0b013e31821e9994
52. Wilkin TJ, Palmer S, Brudney KF, Chiasson MA, Wright TC. Anal intraepithelial neoplasia in heterosexual and homosexual HIV-positive men with access to antiretroviral therapy. J Infect Dis 2004; 190(9): 1685-91. doi:10.1086/424599
53. Palefsky JM, Holly EA, Ralston ML, Jay N. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis 1998; 177(2): 361-7. doi:10.1086/ 514194
54. Critchlow CW, Hawes SE, Kuypers JM, Goldbaum GM, Holmes KK, Surawicz CM, et al. Effect of HIV infection on the natural history of anal human papillomavirus infection. AIDS 1998; 12(10): 1177-84. doi:10.1097/00002030- 199810000-00010
55. Sonnex C, Strauss S, Gray JJ. Detection of human papillomavirus DNA on the fingers of patients with genital warts. Sex Transm Infect 1999; 75(5): 317-9. doi:10.1136/sti.75.5.317
56. Nielson CM, Harris RB, Flores R, Abrahamsen M, Papenfuss MR, Dunne EF, et al. Multiple-type human papillomavirus infection in male anogenital sites: prevalence and associated factors. Cancer Epidemiol Biomarkers Prev 2009; 18(4): 1077-83. doi:10.1158/ 1055-9965.EPI-08-0447
57. Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE. Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst 2011; 103(5): 368-83. doi:10.1093/jnci/ djq562
58. Rodriguez AC, Burk R, Herrero R, Hildesheim A, Bratti C, Sherman ME, et al. The natural history of human papillomavirus infection and cervical intraepithelial neoplasia among young women in the Guanacaste cohort shortly after initiation of sexual life. Sex Transm Dis 2007; 34(7): 494-502.
59. Nyitray AG, Carvalho da Silva RJ, Baggio ML, Smith D, Abrahamsen M, Papenfuss M, et al. Six-month incidence, persistence, and factors associated with persistence of anal human papillomavirus in men: the HPV in men study. J Infect Dis 2011; 204(11): 1711-22. doi:10.1093/ infdis/jir637
60. Palefsky JM, Giuliano AR, Goldstone S, Moreira ED, Aranda C, Jessen H, et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 2011; 365(17): 1576-85. doi:10.1056/NEJMoa1010971
61. Safaeian M, Porras C, Schiffman M, Rodriguez AC, Wacholder S, Gonzalez P, et al. Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections. J Natl Cancer Inst 2010; 102(21): 1653-62. doi:10.1093/jnci/djq384
62. Ho GY, Studentsov Y, Hall CB, Bierman R, Beardsley L, Lempa M, et al. Risk factors for subsequent cervicovaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 virus-like particles. J Infect Dis 2002; 186(6): 737-42. doi:10.1086/342972
63. Malik ZA, Hailpern SM, Burk RD. Persistent antibodies to HPV viruslike particles following natural infection are protective against subsequent cervicovaginal infection with related and unrelated HPV. Viral Immunol 2009; 22(6): 445-9. doi:10.1089/vim.2009.0055
64. de Pokomandy A, Rouleau D, Ghattas G, Vezina S, Cote P, Macleod J, et al. Prevalence, clearance, and incidence of anal human papillomavirus infection in HIV-infected men: the HIPVIRG cohort study. J Infect Dis 2009; 199(7): 965-73. doi:10.1086/597207
65. Poynten IM, Templeton DJ, Grulich AE. Sexually transmissible infections in aging HIV populations. Sex Health 2011; 8(4): 508-11. doi:10.1071/SH11027
66. Shvetsov YB, Hernandez BY, McDuffie K, Wilkens LR, Zhu X, Ning L, et al. Duration and clearance of anal human papillomavirus (HPV) infection among women: the Hawaii HPV cohort study. Clin Infect Dis 2009; 48(5): 536-46. doi:10.1086/596758
67. Bhat P, Mattarollo SR, Gosmann C, Frazer IH, Leggatt GR. Regulation of immune responses to HPV infection and during HPV-directed immunotherapy. Immunol Rev 2011; 239(1): 85-98. doi:10.1111/j.1600-065X.2010.00966.x
68. Gravitt PE. The known unknowns of HPV natural history. J Clin Invest 2011; 121(12): 4593-9. doi:10.1172/JCI57149
69. Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, Massad LS, et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst 2005; 97(8): 577-86. doi:10.1093/jnci/dji073
70. Prestage G, Mao L, Fogarty A, Van de Ven P, Kippax S, Crawford J, et al. How has the sexual behaviour of gay men changed since the onset of AIDS: 1986-2003. Aust N Z J Public Health 2005; 29(6): 530-5. doi:10.1111/j.1467-842X. 2005.tb00245.x
71. Sapp M, Bienkowska-Haba M. Viral entry mechanisms: human papillomavirus and a long journey from extracellular matrix to the nucleus. FEBS J 2009; 276(24): 7206-16. doi:10.1111/j.1742-4658. 2009.07400.x
72. Haase AT. Targeting early infection to prevent HIV-1 mucosal transmission. Nature 2010; 464(7286): 217-23. doi:10.1038/nature 08757
73. Palefsky J. Biology of HPV in HIV infection. Adv Dent Res 2006; 19(1): 99-105. doi:10.1177/154407370601900120
74. Miloševic M, Poljak M, Mlakar B. Anal HPV infection in Slovenian men who have sex with men. Cent Eur J Med 2010; 5(6): 698-703. doi:10.2478/s11536-010-0019-4
75. Conley L, Bush T, Darragh TM, Palefsky JM, Unger ER, Patel P, et al. Factors associated with prevalent abnormal anal cytology in a large cohort of HIV-infected adults in the United States. J Infect Dis 2010; 202(10): 1567-76. doi:10.1086/656775
76. Damay A, Fabre J, Costes V, Didelot JM, Didelot MN, Boulle N, et al. Human papillomavirus (HPV) prevalence and type distribution, and HPV-associated cytological abnormalities in anal specimens from men infected with HIV who have sex with men. J Med Virol 2010; 82(4): 592-6. doi:10.1002/jmv.21732
77. Sirera G, Videla S, Pinol M, Canadas MP, Llatjos M, Ballesteros AL, et al. High prevalence of human papillomavirus infection in the anus, penis and mouth in HIV-positive men. AIDS 2006; 20(8): 1201-4. doi:10.1097/01.aids. 0000226963.10342.f4